TNGX — Tango Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Tango Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	485	366	337	258	343
Net Total Accounts Receivable
Net Total Receivables	2	2	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	492	375	347	266	354
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.09	57.8	53.4	47.6	42.5
Other Long Term Assets
Total Assets	500	436	403	316	399
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	40.7	55.5	45.9	38.2	21.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	155	187	149	117	52.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	345	249	253	200	346
Total Liabilities & Shareholders' Equity	500	436	403	316	399
Total Common Shares Outstanding